HomeCASI • NASDAQ
add
CASI Pharmaceuticals Inc
Previous close
$2.33
Day range
$2.21 - $2.36
Year range
$1.09 - $7.50
Market cap
35.32M USD
Avg Volume
2.50M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 4.18M | 4.93% |
Operating expense | 12.77M | 9.88% |
Net income | -13.38M | -92.06% |
Net profit margin | -320.36 | -83.04% |
Earnings per share | — | — |
EBITDA | -10.13M | -17.52% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.76M | -46.87% |
Total assets | 31.20M | -39.14% |
Total liabilities | 51.51M | 21.92% |
Total equity | -20.31M | — |
Shares outstanding | 15.51M | — |
Price to book | -1.78 | — |
Return on assets | -74.35% | — |
Return on capital | -605.36% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -13.38M | -92.06% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1991
Headquarters
Website
Employees
233
